no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Adaptive Trials in Cardiology: Some Considerations and Examples
|
Mandrola, John |
|
|
37 |
9 |
p. 1428-1437 |
article |
2 |
A Role for Heme and Iron in Calcific Aortic Valve Disease?
|
Chignon, Arnaud |
|
|
37 |
9 |
p. 1310-1311 |
article |
3 |
Bayesian Analyses of Cardiovascular Trials—Bringing Added Value to the Table
|
Brophy, James M. |
|
|
37 |
9 |
p. 1415-1427 |
article |
4 |
Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?
|
Janiaud, Perrine |
|
|
37 |
9 |
p. 1353-1364 |
article |
5 |
Clinical Trials of Heart Failure: Is There a Question of Sex?
|
Sohani, Zahra N. |
|
|
37 |
9 |
p. 1303-1309 |
article |
6 |
Direct-Acting Oral Anticoagulant Choice for Stroke Prevention in Obese Patients With Atrial Fibrillation
|
Brar, Tanveer |
|
|
37 |
9 |
p. 1489-1492 |
article |
7 |
Editorial Board
|
|
|
|
37 |
9 |
p. A1-A2 |
article |
8 |
Emulating a Randomised Controlled Trial With Observational Data: An Introduction to the Target Trial Framework
|
Kutcher, Stephen A. |
|
|
37 |
9 |
p. 1365-1377 |
article |
9 |
IL-18 Promotes Erythrophagocytosis and Erythrocyte Degradation by M1 Macrophages in a Calcific Microenvironment
|
Xu, Ran |
|
|
37 |
9 |
p. 1460-1471 |
article |
10 |
Importance of Internal Variability in Clinical Trials of Cardiovascular Disease
|
Reed, Grant W. |
|
|
37 |
9 |
p. 1404-1414 |
article |
11 |
Influenza Vaccination in Patients With Congenital Heart Disease in the Pre-COVID-19 Era: Coverage Rate, Patient Characteristics, and Outcomes
|
Moons, Philip |
|
|
37 |
9 |
p. 1472-1479 |
article |
12 |
Information for Readers
|
|
|
|
37 |
9 |
p. A6 |
article |
13 |
Issues in Designing and Interpreting Small Clinical Trials
|
Althouse, Andrew D. |
|
|
37 |
9 |
p. 1332-1339 |
article |
14 |
Key Issues in the Statistical Interpretation of Randomized Clinical Trials
|
Brophy, James M. |
|
|
37 |
9 |
p. 1312-1321 |
article |
15 |
Low Skeletal Muscle Mass Is Associated With the Presence, Incidence, and Progression of Coronary Artery Calcification
|
Jun, Ji Eun |
|
|
37 |
9 |
p. 1480-1488 |
article |
16 |
Missing Data in Clinical Research: A Tutorial on Multiple Imputation
|
Austin, Peter C. |
|
|
37 |
9 |
p. 1322-1331 |
article |
17 |
Patient-Reported Outcomes in Cardiovascular Trials
|
Masterson Creber, Ruth |
|
|
37 |
9 |
p. 1340-1352 |
article |
18 |
Table of Contents
|
|
|
|
37 |
9 |
p. A3-A5 |
article |
19 |
The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis
|
Chew, Nicholas W.S. |
|
|
37 |
9 |
p. 1450-1459 |
article |
20 |
Understanding the Merits and Drawbacks of Noninferiority Trials in Cardiovascular Medicine
|
Kaul, Sanjay |
|
|
37 |
9 |
p. 1378-1393 |
article |
21 |
Unique Challenges of Randomised Controlled Trials in Pediatric Cardiology
|
Harris, Kevin C. |
|
|
37 |
9 |
p. 1394-1403 |
article |
22 |
Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review
|
Anchouche, Khalil |
|
|
37 |
9 |
p. 1438-1449 |
article |